Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Daniel Au, MD

Advertisement

Articles by Daniel Au, MD

Photo courtesy of InTouch Health

How artificial intelligence may reshape urologic practice

ByDaniel Au, MD,J. Brantley Thrasher, MD
January 14th 2019

AI is poised to revolutionize use of medical data, but challenges remain.

Advertisement

Latest Updated Articles

  • Photo courtesy of InTouch Health
    How artificial intelligence may reshape urologic practice

    Published: January 14th 2019 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

MRI, myths, and precision: Stacy Loeb, MD, discusses modern prostate cancer screening

2

Sean P. Collins, MD, PhD, outlines the impact of rectal spacers for men with prostate cancer

3

Suzanne Merrill, MD, on integrating ICIs into clinical practice for NMIBC

4

Dual targeting of PAM and AR pathways yields encouraging results in mCRPC

5

Adverse Event Considerations for Prostate Cancer Treatment With Enzalutamide

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us